Might be helpful for readers to recall what you said back on 30 March 2022 to help them decide how much credibility your posts have.
You wrote (see here):
"BIT, being a back-bench biotech, has shown it has remarkable compunds and evidence-driven outcome that it was able to send to FDA's court.
The CEO is showing progress!
BIT, this year, can demonstrate many potential breakthrough - potential outcome from the ongoing works in many fronts, securing commercial partnership deals, SP reaching all-time high around $1 per share, ... My gut feeling. DYOR!"
Take Over Offer is over the cup for sure!, page-3
-
- There are more pages in this discussion • 110 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
-0.001(3.57%) |
Mkt cap ! $24.36M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.7¢ | 2.7¢ | $1.136K | 42.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1950508 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.7¢ | 199924 | 1 |
View Market Depth
| Last trade - 14.29pm 30/08/2024 (20 minute delay) ? |
| BIT (ASX) Chart |